157 related articles for article (PubMed ID: 24550599)
1. Clopidogrel: a possible exacerbating factor for psoriasis.
Mahajan VK; Khatri G; Prabha N; Abhinav C; Sharma V
Indian J Pharmacol; 2014; 46(1):123-4. PubMed ID: 24550599
[TBL] [Abstract][Full Text] [Related]
2. Suberythrodermic pustular psoriasis induced by clopidogrel.
Meissner M; Beier C; Wolter M; Kaufmann R; Gille J
Br J Dermatol; 2006 Sep; 155(3):630-1. PubMed ID: 16911296
[No Abstract] [Full Text] [Related]
3. Comparison of antiplatelet effect and safety of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients: multi-center, randomized, double-blind, phase IV, non-inferiority clinical trial.
Lee S; Lee HY; Park KW; Kang HJ; Koo BK; Kim HS; Choi DJ; Kim MA; Oh BH
Am J Cardiovasc Drugs; 2013 Dec; 13(6):413-24. PubMed ID: 23913405
[TBL] [Abstract][Full Text] [Related]
4. The effect of clopidogrel besylate and clopidogrel hydrogensulfate on platelet aggregation in patients with coronary artery disease: a retrospective study.
Borsiczky B; Sarszegi Z; Konyi A; Szabados S; Gaszner B
Thromb Res; 2012 Jun; 129(6):700-3. PubMed ID: 21924759
[TBL] [Abstract][Full Text] [Related]
5. Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
Olędzki S; Kornacewicz-Jach Z; Safranow K; Kiedrowicz R; Gawrońska-Szklarz B; Jastrzębska M; Gorący J
Eur J Clin Pharmacol; 2017 Sep; 73(9):1085-1094. PubMed ID: 28589365
[TBL] [Abstract][Full Text] [Related]
6. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel desensitization: case report and review of published protocols.
Owen P; Garner J; Hergott L; Page RL
Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
[TBL] [Abstract][Full Text] [Related]
9. Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine.
Maeda A; Ando H; Asai T; Ishiguro H; Umemoto N; Ohta M; Morishima M; Sumida A; Kobayashi T; Hosohata K; Ushijima K; Fujimura A
Clin Pharmacol Ther; 2011 Feb; 89(2):229-33. PubMed ID: 21178986
[TBL] [Abstract][Full Text] [Related]
10. The thienopyridines in coronary artery disease.
Berger PB
Curr Cardiol Rep; 1999 Sep; 1(3):192-8. PubMed ID: 10980841
[TBL] [Abstract][Full Text] [Related]
11. Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.
Arya V; Mahajan P; Saraf A; Mohanty A; Sawhney JP; Bhargava M
Int J Lab Hematol; 2015 Dec; 37(6):809-18. PubMed ID: 26264906
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel.
Huang KW; Luo JC; Leu HB; Huang CC; Hou MC; Chen TS; Lu CL; Lin HC; Lee FY; Chang FY
J Chin Med Assoc; 2013 Jan; 76(1):9-14. PubMed ID: 23331775
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
Diabetes; 2006 Mar; 55(3):780-4. PubMed ID: 16505243
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R
Platelets; 2013; 24(4):297-302. PubMed ID: 22721490
[TBL] [Abstract][Full Text] [Related]
17. Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy.
Nührenberg TG; Stratz C; Leggewie S; Hochholzer W; Valina CM; Gick M; Kirtane AJ; Stone GW; Neumann FJ; Trenk D
Thromb Haemost; 2015 Nov; 114(5):1020-7. PubMed ID: 26305340
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antiplatelet effect of clopidogrel hydrogenosulfate and clopidogrel besylate in patients with stable coronary artery disease.
Hamilos M; Saloustros I; Skalidis E; Igoumenidis N; Kambouris M; Chlouverakis G; Vougia D; Loggakis I; Vardas PE; Kochiadakis G
J Thromb Thrombolysis; 2015 Oct; 40(3):288-93. PubMed ID: 25662861
[TBL] [Abstract][Full Text] [Related]
19. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
[TBL] [Abstract][Full Text] [Related]
20. The role of clopidogrel in the management of patients with ischemic heart disease.
Chopra V; Marmur JD; Cavusoglu E
Cardiovasc Drugs Ther; 2003; 17(5-6):467-77. PubMed ID: 15107602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
